Joshua Morrison

Joshua Morrison, CEO of 1Day Sooner and advocate for scientific advances in infectious disease response, joins the conversation. He shares insights on the successes and failures of Operation Warp Speed in vaccine development. Morrison highlights the need for innovative clean air technologies to improve pandemic preparedness and discusses the importance of effective communication and trust in public health. The conversation also touches on leveraging past experiences to enhance regulatory frameworks for rapid response to future pandemics.

In this engaging discussion, guest Josh Morrison, a serial social entrepreneur, dives into the innovative world of human challenge trials for vaccine development. He explores how these trials could expedite research while addressing ethical complexities and the importance of informed consent. Morrison highlights the need for a balanced approach to accelerate critical health interventions and critiques the often cautious nature of ethics boards. The conversation also touches on the emotional intricacies of altruism in organ donation and its broader societal implications.